NowPatient review
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
- Semaglutide
- From $1,349/mo (brand Wegovy)
- Tirzepatide
- From $1,069/mo (brand Mounjaro, promotional rate)
- Coverage
- Not disclosed
- Brand-name
- Yes
The scorecard
NowPatient scored on our six published factors. See the methodology.
What we like
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
The caveats
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
The verdict
Best for: Shoppers who want brand-name GLP-1 access without a compounded route. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
Ranked #260 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between NovoCare Pharmacy at #259, 66/100 above and PrideRx at #261, 66/100 below, with the YOURx Health ruling the next one down.
If that ruling leaves you undecided, the 7 programs we rank against NowPatient are graded on the same six factors and listed in score order.For the wider picture, every ruling we have published ranks the field on the same six factors. We have also ruled on it directly: CoreAge Rx vs NowPatient goes to CoreAge Rx, 94/100 to 66/100.
Compare with other providers
The closest rulings to NowPatient by Verdict Score — the realistic shortlist if you are weighing this one up.
- #224Velvet Rx— Velvet Rx (velvetrx.com) is a cash-pay telehealth platform offering compounded semaglutide, compounded tirzepatide, and an oral GLP-1 across three publicly-listed SKUs ranging from $139 to $199 'today'…68/100
- #225Willow— Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.68/100
- #226Fierce Health— Fierce Health is a direct-to-consumer telehealth brand selling compounded semaglutide and tirzepatide in both standard and microdose programs, alongside a longevity catalog.68/100
- #227Found— An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.65/100
- #228System Labs— One flat $179 a month at every dose, month to month, with a named medical board standing behind it — but a single tirzepatide program, no semaglutide at all, an unnamed pharmacy and no published state list.65/100
- #229Belle Health— Nine-year-old Utah telehealth firm offering compounded and brand GLP-1s in all fifty states, carrying an FDA warning letter from February 2026.67/100
Pricing, states and verification reflect NowPatient's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.